Ashland Performance Materials Signs Distribution Agreement with GRPMS

Ashland Performance Materials, a commercial unit of Ashland Inc has signed a new distribution agreement that covers its complete portfolio of high-performance composites and structural adhesives products in France.

Effective Dec. 1, GRPMS will take over Ashland’s distribution and agency accounts from Azelis France (Arnaud S.A.), and will distribute Ashland’s full line of polyester, acrylic, phenolic and vinyl ester resins, including the Derakane resin brand. Also included in the agreement for the French composites market are the Pliogrip branded structural adhesives, as well as premium gelcoats and low-profile additives.

GRPMS, an UMECO company, is currently the distributor for Ashland’s complete portfolio of high-performance composites products to manufacturers in the UK, Scandinavia and Estonia. The two companies also entered into an agreement covering Finland that went into effect Oct. 1.

“For nearly 30 years, Ashland and GRPMS have been building a strong partnership focused on serving composites manufacturers in markets across Europe,” said Stefan Osterwind, commercial director, Europe, Ashland Performance Materials.

“We are excited for this opportunity to expand on our long-term relationship with Ashland,” said Anthony Bibby, managing director, GRPMS Ltd. “Ashland’s portfolio of technologies is recognized in the industry for their performance and versatility in a variety of applications, and we are committed to delivering improved logistics and technical service capabilities to composites customers in France.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.